Class III β-tubulin overexpression within the tumor microenvironment is a prognostic biomarker for poor overall survival in ovarian cancer patients treated with neoadjuvant carboplatin/paclitaxel

Dana M. Roque, Natalia Buza, Michelle Glasgow, Stefania Bellone, Ileana Bortolomai, Sara Gasparrini, Emiliano Cocco, Elena Ratner, Dan Arin Silasi, Masoud Azodi, Thomas J. Rutherford, Peter E. Schwartz, Alessandro D. Santin

Research output: Contribution to journal › Article › peer-review

40 Scopus citations

Fingerprint

Dive into the research topics of 'Class III β-tubulin overexpression within the tumor microenvironment is a prognostic biomarker for poor overall survival in ovarian cancer patients treated with neoadjuvant carboplatin/paclitaxel'. Together they form a unique fingerprint.

Medicine & Life Sciences